ASCO & ACCC Join Forces to Boost African American & Latino Participation in Cancer Clinical Trials

ASCO & ACCC Join Forces to Boost African American & Latino Participation in Cancer Clinical Trials

Two prominent forces in United States-based cancer research came together to drive greater diversity in clinical research. For too long, clinical trial participation hasn’t represented the demographics of the American population at large. The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) have formed a joint initiative designed to identify and implement novel strategies and practical solutions to increase clinical trial participation of racial and ethnic minority populations that continue to be under-represented in cancer research. Of particular concern is to boost the participation of two of America’s largest minority groups, namely African Americans and Hispanics (Latinos).


According to recent analyses, African Americans represent 4% to 6% of trial participants, while Hispanics/Latinos represent 3% to 6%. Yet Blacks represent at least 15% and Latino/Hispanic 13% of all cancer cases. Lori J. Pierce, MD, FASTRO, FASCO, co-chair of the ASCO-ACCC Steering Group, is overseeing this initiative: “We are committed to providing evidence-based high-quality cancer care to every patient, every day, everywhere.” She conti...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee